Statistics for Long-term cost-effectiveness of tight control for Crohn-s disease with adalimumab-based treatment: economic evaluation beyond 48 weeks of CALM trial
Total visits
views | |
---|---|
Long-term cost-effectiveness of tight control for Crohn-s disease with adalimumab-based treatment: economic evaluation beyond 48 weeks of CALM trial | 0 |
Total visits per month
views | |
---|---|
November 2022 | 0 |
December 2022 | 0 |
January 2023 | 0 |
February 2023 | 0 |
March 2023 | 0 |
April 2023 | 0 |
May 2023 | 0 |